Table 1.
Detailed characteristics of the included studies in the meta-analysis, concerning the uKIM-1 biomarker for controls and T2DM patients with normoalbuminuria.
| First Author’ s Name, Year (Reference) | Country | Sample Size (n) | Sex (%Male) | Age | Definition of Albuminuria for T2DM Patients | Method of uKIM-1 Measurement | Variables Provided | |||
|---|---|---|---|---|---|---|---|---|---|---|
| Controls | Patients | Controls | Patients | Controls | Patients | |||||
| Kim SS, 2012 [29] | Republic of Korea | 25 | 58 | 56.0 | 39.6 | 50.9 | 57 | Normoalbuminuria: uACR < 30 mg/g | ELISA (R &D systems) |
Median + IQR |
| El-Attar HA, 2017 [30] | Egypt | 20 | 20 | 45.1 | 50.0 | 39.5 | 39.5 | Normoalbuminuria uACR < 30 mg/g |
ELISA | Median+ min, max |
| Fu Wen-jin, 2012 [31] | China | 28 | 61 | 46.4 | - | 48.3 | - | Normoalbuminuria uACR < 30 mg/g |
ELISA (Quantikine R & D) |
Median + IQR |
| El-Ashmawy NE., 2015 [32] | Egypt | 20 | 30 | 50.0 | 33.3 | 51.6 | 60.2 | Normoalbuminuria uACR < 30 mg/g |
ELISA (Adibo Bioscience) |
Mean + SD |
| Ali SI., 2017 [33] | Egypt | 19 | 24 | 42.8 | - | 45.0 | - | Normoalbuminuria uACR < 30 mg/g |
ELISA (Glory Diagnostics) |
Mean + SD |
| Kin Tekce B, 2014 [34] | Turkey | 34 | 39 | 47.0 | 46.1 | 59 | 62 | Normoalbuminuria uACR < 30 mg/g |
ELISA (Aviscera Bioscience) |
Mean + SD |
| Aslan O, 2014 [35] | Turkey | 20 | 20 | 0 | 0 | 48.4 | 52.1 | Normoalbuminuria uACR < 30 mg/g |
ELISA (USCN) |
Mean + SD |
| Gao P, 2018 [36] | USA | 30 | 30 | 50.0 | 53.3 | 48.1 | 50.1 | Normoalbuminuria uACR < 30 mg/g |
ELISA (USCN) |
Median + IQR |